Latest Proprietary Technology News

PMET Resources says Koch Technology Solutions has demonstrated a more selective pathway for turning Shaakichiuwaanaan pollucite concentrate into multiple high-purity caesium chemicals. The result is promising, but the commercial case still depends on larger-scale testing, marketable samples and a planned economic assessment.

Vulcan Energy has started commercial-scale production in Germany of VULSORB, the proprietary adsorbent at the centre of its planned direct lithium extraction process. The material will supply first-fill volumes for Project Lionheart, although lithium production remains targeted for the second half of 2028.

Corporate Travel Management (ASX:CTD) has posted a $17.7 million net profit for FY26, reversing a prior $348.5 million loss, supported by UK client settlements, new debt facilities, and a governance uplift program.

Wide Open Agriculture cut its loss to $3.64 million in FY2026 as it pivots from owning manufacturing to a capital-light contract model, while securing global commercial traction for its lupin-based ingredients.

IperionX has landed a second U.S. Army task order worth US$11.5 million to expand its industrial-scale titanium manufacturing capacity in Virginia, advancing its integrated powder-to-part platform for defense applications.

Pengana Capital Group reported a statutory loss of $5.6 million for FY26 despite a 14% rise in funds under management, driven by upfront costs linked to new product launches and expanding private credit platforms.

AnteoTech has formalised a strategic alliance with South Korea’s Xerabrid to co-develop and commercialise a breakthrough battery separator combining their proprietary technologies, targeting high-performance applications in eVTOL, EVs, and consumer electronics.

Servcorp Limited delivered a record FY26 with a 24% rise in underlying NPBIT to $87 million, boosted dividends by 14%, and outlined a cautious yet optimistic FY27 growth strategy.

Wide Open Agriculture (ASX: WOA) has taken a significant step towards a capital-light production model by signing a non-binding framework agreement with Proeon Foods for contract manufacturing of its lupin-based ingredients, including exclusive Indian distribution rights.

Clarity Pharmaceuticals has presented compelling clinical evidence that its investigational 64Cu-SAR-bisPSMA diagnostic and 67Cu-SAR-bisPSMA therapeutic candidates outperform current standards in prostate cancer care, positioning the company for regulatory and commercial milestones.

Acrux Limited spotlighted its Female Testosterone Metered Dose Transdermal System (MDTS) at the Bioshares Biotech Summit, revealing positive Phase II data and outlining a clear regulatory and commercial roadmap targeting Hypoactive Sexual Desire Disorder (HSDD) in women.

OM Holdings' subsidiary OM Materials has locked in a binding take-or-pay deal to purchase up to 1.1 million tonnes per annum of manganese concentrate from Element 25's Butcherbird Mine, underpinning Element 25's expansion and financing plans.